Cite
APA Citation
Raghav, K. P., Stephen, B., Karp, D. D., Piha-Paul, S. A., Hong, D. S., Jain, D., Chudy Onwugaje, D. O., Abonofal, A., Willett, A. F., Overman, M., Smaglo, B., Huey, R. W., Meric-Bernstam, F., Varadhachary, G. R., & Naing, A. (2022). efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial. Journal for immunotherapy of cancer, 10(5), . http://access.bl.uk/ark:/81055/vdc_100155150559.0x00000f